Synergistic Effect of Bazedoxifene and PARP Inhibitor in the Treatment of Ovarian Cancer Regardless of BRCA Mutation
Ruijie Zhang(Tongji Hospital), Jiayuh Lin(Nationwide Children's Hospital)
Cited by 10
Related Papers
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
|Cancer Research|2010|233
Stat3 activation in human endometrial and cervical cancers
|British Journal of Cancer|2007|164
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
|British Journal of Cancer|2005|150
LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
|British Journal of Cancer|2009|93